🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Investigating the $66K Congressional Sell-Off of UnitedHealth Group Stock

Published 09/05/2023, 15:16
Updated 09/05/2023, 16:40
© Reuters.  Investigating the $66K Congressional Sell-Off of UnitedHealth Group Stock
UNH
-

Benzinga - Over the past three months, congress has sold over $66K dollars worth of UnitedHealth Group (NYSE:UNH) stock. A total of 3 transactions have taken place by 3 different congressional members with Daniel Goldman selling the most, totaling $50,001.00 worth of UNH stock.

Congressional Transactions for UNH Over Past 3 Months

Member NameChamberSymbolCompanyTransaction DateTransaction TypeAmount
Daniel Goldman UNH UnitedHealth Group House 2023-03-06 S (Partial) $50,001.00
John Curtis UNH UnitedHealth Group House 2023-02-23 S (Partial) $1,001.00
Scott Franklin UNH UnitedHealth Group House 2023-02-15 S (Partial) $15,001.00
Given the recent sell-side activity from congressional members, it leads one to question UnitedHealth Group's future. First let's look at how UnitedHealth Group has been performing recently.

As you can see, despite the recent sell-off by members of Congress, UnitedHealth Group has performed well over the past three months, achieving a 2.73% return.

Recap Over the past three months, 3 congressional members have sold over $66K dollars worth of UnitedHealth Group stock, while the stock has gained 2.73% over the same timeframe.

The recent sell-side activity by congress could be a result of members capitalizing on gains if they believe the current trend will not continue. On the other hand, congressional members can sell stock for a variety of reasons, including personal financial needs or diversification of their investment portfolios, so it's important to keep a balanced perspective and look at the company's performance holistically.

As always, investors should conduct their due diligence and consider other factors, such as a company's financials, analyst ratings, and broader market trends, before making any investment decisions.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.